Monoethanolamine

Monoethanolamine

SCHEMBL28054142

NCCO.O=C1C=CC(=O)N1CC1CCCCC1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
OPRL1 P41146 3/20 0.39
OPRM1 P35372 2/20 0.39
CYP1B1 Q16678 3/20 0.39
CYP19A1 P11511 2/20 0.39
TRPA1 O75762 4/20 0.37
GLA P06280 1/20 0.36
BACE1 P56817 1/20 0.36
OPRK1 P41145 1/20 0.33
CHRM5 P08912 1/20 0.33
ADRA2C P18825 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21419553 0.88 CYP1B1 (0.45) KDM4ELMNATP53MAPK1SMN1; SMN2
SCHEMBL19176752 0.88 CYP1B1 (0.45) KDM4ELMNATP53MAPK1SMN1; SMN2
SCHEMBL1275809 0.88 CYP1B1 (0.45) KDM4ELMNATP53MAPK1SMN1; SMN2
Bicarbonate SCHEMBL2319198 0.84 TRPA1 (0.46) OPRL1CYP1B1CYP19A1TRPA1
SCHEMBL20365061 0.82 CYP1B1 (0.44) LMNATP53MAPK1SMN1; SMN2OPRL1
SCHEMBL485615 0.78 MGLL (0.44) LMNATP53MAPK1SMN1; SMN2CYP1B1
SCHEMBL3828808 0.76 CYP1B1 (0.40) LMNATP53MAPK1SMN1; SMN2CYP1B1
SCHEMBL1766181 0.75 PTGS1 (0.36) TDP1CYP1A2HIF1AOPRL1OPRM1
SCHEMBL18279974 0.75 TRPA1 (0.40) CYP1B1TRPA1
SCHEMBL28952214 0.73 MGLL (0.37) LMNATP53MAPK1SMN1; SMN2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105267233-A Compositions and methods for inhibiting expression of Eg5 and VEGF genes ALNYLAM PHARMACEUTICALS INC 2016-01-27 CN disclosed